Stock screener

ALKS

Conviction 100HealthcareScan · Thu, Jun 25, 2026
ALKS$52.84+4.73%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 3.13M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Alkermes plc.PHARMACEUTICAL PREPARATIONSwww.alkermes.com ↗
Price52.84
Change+4.73%
Gap+0.48%
Rel volume4.50×
Avg volume2.99M
Avg $ vol137.51M
SMA 2044.49
SMA 5039.07
SMA 20032.58
Price vs 50+35.22%
Price vs 200+62.18%
MA stackbullish
50/200 cross—
Supertrendup · 46.08
RSI (14)86
MACD hist0.60
MACD crossbull · 3d
Stoch %K / %D93 / 92
ADX (14)49
+DI / −DI47 / 6
RSI divergence—
MACD divergenceBearish
ATR %+3.57%
ADR %4.23%
52w high52.84
52w low26.13
From 52w high+0.00%
Above 52w low+102.20%
New 52w highYes
SqueezeOff
Bollinger width26.49%
%B1.21
Donchian pos94.86%
Donchian high53.65
Donchian low37.80
AVWAP (52w high)52.39
vs AVWAP high+0.85%
AVWAP (52w low)33.12
vs AVWAP low+59.52%
OBV trendUp
Chaikin MF (20)0.19
Today vs 20d4.50×
Avg vol (14d)3.13M
Avg vol (20d)2.99M
Avg $ vol (20d)137.51M
Market cap8.81B
RS 3m (vs SPY)+65.38%
RS 6m (vs SPY)+69.59%
RS line new highYes
Trend template8/8
Technical rank95.8
1 week+18.70%
1 month+41.46%
3 months+79.89%
6 months+84.54%
1 year+80.02%
YTD+86.96%
P/E36.44
P/B5.03
P/S5.97
P/FCF18.33
EPS1.43
Div yield—
ROE13.80%
ROA5.68%
Debt/Eq0.86
Current2.27
EV/EBITDA35.45
Gross margin—
Net margin16.37%
Rev growth-5.25%
EPS growth-34.16%
Price target50.00
Target upside-5.37%
Analyst ratingBuy
Institutional123.22%
Ent. value9.97B
Revenue392.91M
Net income-66.48M
Gross profit—
Free cash flow480.33M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out166.68M
Employees2.05K
ListedTue, Jul 16, 1991
Free float162.41M
Float %98.4%
Short interest17.36M
Days to cover8.4d
Short volume60.6%
Squeeze score75 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.04 · 5 est
Last EPS vs est−$0.40 vs −$0.57
Last surprise+29.8% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank95.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance45.17
Support34.00
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALKS

All disclosures →
No recent disclosed trades by Congress in ALKS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALKS · 3 buys · 7 sells

InsiderSideShares
Wright Christopher I
Director · Ordinary Shares · 2026-06-12
Sell2K
Gaffin David Joseph
EVP, CLO, Alkermes, Inc. · Ordinary Shares · 2026-06-04
Sell2.03K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · Ordinary Shares · 2026-06-01
Exercise5K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · Ordinary Shares · 2026-06-01
Sell9K
Hopkinson Craig C.
EVP R&D, Chief Medical Officer · Employee Stock Option (Right to Buy) · 2026-06-01
Exercise5K
Parisi Samuel Joseph
VP, Finance (Interim PAO) · Ordinary Shares · 2026-05-29
Sell16.22K
Parisi Samuel Joseph
VP, Finance (Interim PAO) · Ordinary Shares · 2026-05-29
Exercise12.82K
Parisi Samuel Joseph
VP, Finance (Interim PAO) · Ordinary Shares · 2026-05-29
Exercise3.39K
Parisi Samuel Joseph
VP, Finance (Interim PAO) · Employee Stock Option (Right to Buy) · 2026-05-29
Exercise3.39K
Parisi Samuel Joseph
VP, Finance (Interim PAO) · Employee Stock Option (Right to Buy) · 2026-05-29
Exercise12.82K

SEC filings

EDGAR filings in ALKS · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.